Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library
Necroptosis, a caspase-independent regulated cell death, is primarily mediated by the serine/threonine kinases RIPK1 and RIPK3, and the mixed lineage kinase domain-like protein (MLKL). Targeting necroptosis is a validated therapeutic strategy for various diseases. We screened compound 1, a novel ben...
Saved in:
Main Authors: | Yu Zou (Author), Yue Chai (Author), Hongming Shao (Author), Shuyu Wang (Author), Ruilin Hou (Author), Runhui Liu (Author), Linjing Zhao (Author), Chunlin Zhuang (Author) |
---|---|
Format: | Book |
Published: |
Georg Thieme Verlag KG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methodology of drug screening and target identification for new necroptosis inhibitors
by: Pengchao Pan, et al.
Published: (2019) -
Discovery of genomic intervals that underlie nematode responses to benzimidazoles.
by: Mostafa Zamanian, et al.
Published: (2018) -
Synthesis of Antimicrobial Benzimidazole-Pyrazole Compounds and Their Biological Activities
by: Maria Marinescu
Published: (2021) -
Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
by: Jing Zhu, et al.
Published: (2021) -
Benzimidazole
Published: (2022)